Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Trials & Approvals

Inmagene and HutchMed Start Global Trial of BTK Inhibitor
ImmVira Granted US Orphan Drug Status for Oncolytic Virus Candidate in Glioma
ProfoundBio Cleared to Start US Trials of ADC for Solid Tumor Cancers
Zenas to Start China Trials of Thyroid Eye Disease Therapy
Denovo Starts Global Phase II Trial of Precision Medicine for Resistant Depression
ChinaBio Event
Beijing and Digital
November 8-11, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022